Mutual Of America Capital Management LLC Theravance Biopharma, Inc. Transaction History

Mutual Of America Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.77 - $14.41 $536,793 - $1.14 Million	-79,290 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$14.52 - $22.46 $49,513 - $76,588	-3,410 Reduced 4.12%	79,290 $1.15 Million
Q1 2021 May 13, 2021	SELL	$16.57 - $21.08 $75,973 - $96,651	-4,585 Reduced 5.25%	82,700 $1.69 Million
Q4 2020 Feb 12, 2021	SELL	$14.89 - $20.16 $27,457 - $37,175	-1,844 Reduced 2.07%	87,285 $1.55 Million
Q3 2020 Nov 13, 2020	BUY	$14.79 - $22.49 $1.32 Million - $2 Million	89,129 New	89,129 $1.32 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $665M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.